The Government have invested approximately £1 billion through two life sciences sector deals, helping to generate significant industry investment in the UK. Last year the industry had a turnover in the UK of £80.7 billion.
The life sciences sector is a truly international endeavour, as can be so clearly seen with the recent vaccine research efforts. With worries in the sector about our ongoing relationship with European countries and the European Union, would my hon. Friend confirm that the concerns of the life sciences sector are of paramount importance in the ongoing negotiations?
Clearly, the UK’s relationship with the EU is subject to ongoing negotiations, but as we leave the EU the life sciences sector will be supported through the life sciences sector deals that I mentioned, and a new, innovative regulatory framework. The Medicines and Healthcare Products Regulatory Agency has proven itself globally to be one of the finest regulators in the world, and new international regulatory collaborations are on the way too.